The receptor binding domain (RBD) of the SARS-CoV-2 spikeproteinis an important diagnostic and therapeutic target since it binds tothe peptidase domain of the angiotensin-converting enzyme 2 (ACE2)receptor, thus facilitating infection by the virus. This evidence concerns the gene LAP3 and infection.